We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: orth America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Aztreonam Powder for Injection
Therapeutic indications
The treatment of the following infections caused by susceptible aerobic Gram-negative micro-organisms: ·Urinary tract infections Gonorrhoea ·Gonorrhoea ·Lower respiratory tract infections ·Bacteraemia/septicaemia.·Bone and joint infections.· Skin and soft tissue infections ·Intra-abdominal infections ·Gynaecological infections ·adjunctive therapy to surgery in the management of infections caused by susceptible organisms ·Patients with serious Pseudomonas infections may benefit from concurrent use of Aztreonam and an aminoglycoside because of their synergistic action.
Dose and method of administration
Intramuscular or intravenous injection, or intravenous infusion.
Adults:The dose range of Aztreonam is 1 to 8 g daily in equally divided doses. The usual dose is 3 to 4 g daily. The maximum recommended dose is 8 g daily. The dosage and route of administration should be determined by the susceptibility of the causative organisms, severity of infection and the condition of the patient.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
